ArticleFrontiers in genetics2024
S-DCNN: prediction of ATP binding residues by deep convolutional neural network based on SMOTE.
Article in Frontiers in genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The realization of many protein functions requires binding with ligands. As a significant protein-binding ligand, ATP plays a crucial role in various biological processes. Currently, the precise prediction of ATP binding residues remains challenging. Methods: Based on the sequence information, this paper introduces a method called S-DCNN for predicting ATP binding residues, utilizing a deep convolutional neural network (DCNN) enhanced with the synthetic minority over-sampling technique (SMOTE). Results: The incorporation of additional feature parameters such as dihedral angles, energy, and propensity factors into the standard parameter set resulted in a significant enhancement in prediction accuracy on the ATP-289 dataset. The S-DCNN achieved the highest Matthews correlation coefficient value of 0.5031 and an accuracy rate of 97.06% on an independent test set. Furthermore, when applied to the ATP-221 and ATP-388 datasets for validation, the S-DCNN outperformed existing methods on ATP-221 and performed comparably to other methods on ATP-388 during independent testing. Conclusion: Our experimental results underscore the efficacy of the S-DCNN in accurately predicting ATP binding residues, establishing it as a potent tool in the prediction of ATP binding residues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.